Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538Phase 2Terminated
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone in ischemic stroke, sponsored by Shionogi & Co., Ltd.. Started Nov 2017; status: terminated.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03346538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346538.